AbbVie Inc. (ABBV) will begin trading ex-dividend on July 14, 2021. A cash dividend payment of $1.3 per share is scheduled to be paid on August 16, 2021. Shareholders who purchased ABBV prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that ABBV has paid the same dividend. At the current stock price of $117.63, the dividend yield is 4.42%.
The previous trading day's last sale of ABBV was $117.63, representing a -0.61% decrease from the 52 week high of $118.35 and a 48.69% increase over the 52 week low of $79.11.
ABBV is a part of the Health Care sector, which includes companies such as McKesson Corporation (MCK) and AmerisourceBergen Corporation (Holding Co) (ABC). ABBV's current earnings per share, an indicator of a company's profitability, is $2.83. Zacks Investment Research reports ABBV's forecasted earnings growth in 2021 as 19.51%, compared to an industry average of 7%.
For more information on the declaration, record and payment dates, visit the ABBV Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to ABBV through an Exchange Traded Fund [ETF]?
The following ETF(s) have ABBV as a top-10 holding:
- First Trust Nasdaq Pharmaceuticals ETF (ABBV)
- First Trust Morningstar ETF (ABBV)
- WBI Bull-Bear Rising Income 1000 ETF (ABBV)
- WBI BullBear Value 3000 ETF (ABBV)
- WBI BullBear Yield 3000 ETF (ABBV).
The top-performing ETF of this group is WBIG with an increase of 9.14% over the last 100 days. FTXH has the highest percent weighting of ABBV at 8.12%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
